Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer

Adverse reactions to capecitabine-based chemotherapy limit full administration of cytotoxic agents. Likewise, genetic variations associated with capecitabine-related adverse reactions are associated with controversial results and a low predictive value. Thus, more evidence on the role of these varia...

Descripción completa

Detalles Bibliográficos
Autores principales: García-González, Xandra, Cortejoso, Lucía, García, María I., García-Alfonso, Pilar, Robles, Luis, Grávalos, Cristina, González-Haba, Eva, Marta, Pellicer, Sanjurjo, María, López-Fernández, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467446/
https://www.ncbi.nlm.nih.gov/pubmed/25691056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467446/
https://www.ncbi.nlm.nih.gov/pubmed/25691056

Ejemplares similares